Skip to main content
SupplementScience

Benefits of NMN

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • NAD+ restoration — a 2022 clinical trial (Yi et al.) demonstrated that 250mg NMN daily for 12 weeks significantly increased blood NAD+ levels in healthy middle-aged adults, confirming oral bioavailability in humans
  • Insulin sensitivity — a randomized controlled trial by Yoshino et al. (2021) in postmenopausal women with prediabetes found that 250mg NMN daily for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25%
  • Muscle function and aerobic capacity — Liao et al. (2022) reported that NMN supplementation at 600-1200mg daily improved aerobic capacity and endurance in recreational runners over a 6-week period
  • DNA repair and sirtuin activation — NAD+ is a required cofactor for SIRT1-SIRT7 enzymes, which regulate DNA repair, inflammation, and metabolic homeostasis; restoring NAD+ levels reactivates these pathways
  • Mitochondrial health — preclinical studies consistently show NMN rescues age-related mitochondrial dysfunction, though human confirmation is ongoing

What the Research Says

NMN research has progressed rapidly from animal models to human trials. Yi et al. (2022) confirmed oral NMN bioavailability and NAD+ elevation in humans. Yoshino et al. (2021) published the first placebo-controlled trial showing metabolic benefits (improved insulin sensitivity) in postmenopausal women. Liao et al. (2022) demonstrated exercise performance improvements in recreational runners. The NMN vs NR (nicotinamide riboside) debate continues — both raise NAD+, but NMN may have a slight edge in direct conversion efficiency since it is one enzymatic step closer to NAD+. David Sinclair's work at Harvard has driven public interest, though his research is primarily in mice. The field awaits larger, longer-duration human trials to confirm longevity-specific outcomes.

References

  1. (). The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. DOI
  2. (). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. DOI
  3. (). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition. DOI